A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Amifostine
Amifampridine
The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Romidepsin.
Amifostine
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Romidepsin.
Amifostine
Melperone
The risk or severity of QTc prolongation can be increased when Melperone is combined with Romidepsin.
Amifostine
Butriptyline
The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Romidepsin.
Amifostine
Eperisone
The risk or severity of QTc prolongation can be increased when Eperisone is combined with Romidepsin.
Amifostine
Fendiline
The risk or severity of QTc prolongation can be increased when Fendiline is combined with Romidepsin.
Amifostine
Bedaquiline
The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Romidepsin.
Amifostine
Antazoline
The risk or severity of QTc prolongation can be increased when Antazoline is combined with Romidepsin.
Amifostine
Panobinostat
The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Romidepsin.
Amifostine
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Romidepsin.
Amifostine
Telavancin
The risk or severity of QTc prolongation can be increased when Telavancin is combined with Romidepsin.
Amifostine
Tucidinostat
The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Romidepsin.
Amifostine
Tedisamil
The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Romidepsin.
Amifostine
Garenoxacin
The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Romidepsin.
Amifostine
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Romidepsin.
Amifostine
Pracinostat
The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Romidepsin.
Amifostine
Azimilide
The risk or severity of QTc prolongation can be increased when Azimilide is combined with Romidepsin.
Amifostine
Fluspirilene
The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Romidepsin.
Amifostine
Prenylamine
The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Romidepsin.
Amifostine
Terlipressin
The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Romidepsin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3